论文信息 - Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia - 字舞流文

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

A. Kater | M. V. van Oers | R. Raymakers | J. Doorduijn | J. Kerst | M. Levin | M. Schipperus | J. Driessen | M. Chamuleau | S. Wittebol | S. Kersting | E. Marijt | M. Hoogendoorn | M. van Gelder | Y. van Norden | J. Dobber | M. Nijland | M. Schaafsma | W. Posthuma | L. van der Straten | F. De Croon